FDA Approves Gout Drug

Seattle – Takeda Pharmaceuticals created Uloric to treat gout.

The FDA (Food and Drug Administration) approved this drug in 40 mg. and 80 mg. doses. Takeda requested approval in the 80 mg. and 120 mg. doses. However, the FDA denied this request, because they were concerned about potential cardiovascular side effects in the higher doses.

Takeda should take pride in the creation of Uloric, because it is the first treatment created for gout in over 4o years! Gout is a chronic condition that is very painful and affects more than 5 million Americans.

It is the most common form of inflammatory arthritis found in men 40 years and older. Increased levels of uric acid build up in the joints, blood, and tissue causing this extremely painful condition called gout.
Takeda held clinical trials involving Uloric in more than 4,000 people. Common side affects that they found were liver function abnormalties, nausea, joint pain, and rash.